ArticleAnnals of translational medicine2021

Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China.

Runqin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.